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Abstract
Background: The EQ-5D has been frequently used in national health surveys. This study is a head-to-head comparison
to assess how expanding the number of levels from three (EQ-5D-3L) to five in the new EQ-5D-5L version has
improved its distribution, discriminatory power, and validity in the general population.
Methods: A representative sample (N = 7554) from the Catalan Health Interview Survey 2011–2012, aged ≥18, answered
both EQ-5D versions, and we evaluated the response redistribution and inconsistencies between them. To assess validity
of this redistribution, we calculated the mean of the Visual Analogue Scale (VAS), which measures perceived health. The
discriminatory power was examined with Shannon Indices, calculated for each dimension separately. Spanish preference
value sets were applied to obtain utility indices, examining their distribution with statistics of central tendency and
dispersion. We estimated the proportion of individuals reporting the best health state in EQ-5D-5L and EQ-5D-3L within
groups of specific chronic conditions and their VAS mean.
Results: A very small reduction in the percentage of individuals with the best health state was observed, from 61.8% in
EQ-5D-3L to 60.8% in EQ-5D-5L. In contrast, a large proportion of individuals reporting extreme problems in the 3 L
version moved to severe problems (level 4) in the 5 L version, particularly for pain/discomfort (75.5%) and anxiety/
depression (66.4%). The average proportion of inconsistencies was 0.9%. The pattern of the perceived health VAS mean
confirmed the hypothesis established a priori, supporting the validity of the observed redistribution. Shannon index
showed that absolute informativity was higher in the 5 L version for all dimensions. The means (SD) of the Spanish EQ-
5D-3L and EQ-5D-5L indices were 0.87 (0.25) and 0.89 (0.22). The proportion of individuals with the best health state
within each specific chronic condition was very similar, regardless of the EQ-5D version (≤ 30% in half of the 28 chronic
conditions).
Conclusion: Although the proportion of individuals with the best possible health state is still very high, our findings
support that the increase of levels provided by the EQ-5D-5L contributed to the validity and discriminatory power of this
new version to measure health in general population, as in the national health surveys.
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Background
Health-related quality of life has been gaining importance
in research, clinical practice and health planning [1, 2] by
providing complementary information to health indicators
based on morbidity and mortality. This is especially rele-
vant to describe health in developed countries, where life
expectancy has been increasing steadily after their epi-
demiological transition. Evaluating the general popula-
tion’s health is one of the specific applications proposed
for health-related quality of life instruments [3].
The EQ-5D has been frequently selected for national
health surveys [4–10], given its low respondent burden and
its consistently proven metric properties [6, 11, 12] . How-
ever, the high percentage of individuals with the best health
state in the EQ-5D [13, 14] has been repeatedly highlighted
as a limitation, since this may reduce its capacity to dis-
criminate within good health [6, 15, 16], and its responsive-
ness in some health areas [17–19]. The traditional EQ-5D
descriptive system, composed of five dimensions (mobility,
self-care, usual activities, pain/discomfort, and anxiety/de-
pression) with three levels of severity, defines 243 distinct
health states [20] resulting from all the possible combina-
tions (i.e., 35). This is a very low number compared with
other instruments, such as the Health Utilities Index [21]
with 972,000 or the SF-6D [22] with 18,000 possible
combinations.
To improve its discriminative capacity and sensitivity to
change, and to reduce ceiling effects, the EuroQol Research
Foundation decided to develop a new EQ-5D version in-
creasing the number of response options from three
(EQ-5D-3L) to five levels (EQ-5D-5L), resulting in 3125
health states (i.e., 55). Face and content validity of the new
EQ-5D-5L were demonstrated for both the English and
Spanish versions through focus group research [23]. Studies
performed in cancer [24, 25], hepatitis B [26], or hip arthro-
plasty [27] patients showed improvements for discrimina-
tive capacity [24, 26], construct validity [24–26], and
responsiveness, without diminishing its reliability [25], as
well as a large decrease in the percentage of individuals
with the best health state.
Given the recent development of the EQ-5D-5L, there
are still few head-to-head studies in general population
comparing its metric properties with the traditional 3 L
version. Studies carried out in South Korea [28], Alberta
(Canada) [29], England [30] and Lombardy (Italy) [31],
mainly based on national health surveys, examined both
versions of EQ-5D in general population. Yet the South
Korean study published in 2013 [28] was performed only
in a small sample (n = 600), neither the Canadian [29] nor
the English health surveys [30] administered both versions
together, while the Italian survey did, but without compar-
ing them. The decrease in the percentage of individuals
with the best health state varied in these studies, from
42.1 to 32.3% in Alberta [29], from 56.2 to 47.6% in
England [30], from 43.9 to 38% in Lombardy [31], and
from 65.7 to 61.2% in South Korea [28]. The aim of this
study is a head-to-head comparison to assess to what ex-
tent expanding the number of levels in the EQ-5D from
three to five has improved its distribution, discriminatory
power, and validity in the general population.
Methods
Study population
Data used in this study came from the Catalan Health
Interview Survey (CHIS), a continuous cross-sectional
study carried out since 2010 in Catalonia [32], an Autono-
mous Community in the northeast of Spain with about
seven million inhabitants. A representative sample of Cata-
lonia’s non-institutionalized population, without any age
limit, is surveyed through computer-assisted personal inter-
views administered by an accredited team of interviewers in
the respondent’s home. The CHIS was approved by the
Consultants’ Committee of Confidential Information Man-
agement at the Catalan Health Department, according to
the 2000 revision of the Helsinki Declaration.
Information collection is based on an uninterrupted
random sampling strategy divided into waves with 6
months of duration. Each wave has an independent sub-
sample of around 2500 individuals of all ages (representa-
tive of the Autonomous Community population), and a
complete cycle is composed of eight waves with around
20,000 participants interviewed over 4 years (representa-
tive of the healthcare-governing districts).
Study design
The CHIS complex sampling process was designed to en-
sure the territorial representativeness of the sample in
every wave, taking into account the distribution of the
Catalan population. In a first stage, health care-governing
districts were systematically selected. At a second stage,
municipalities were chosen at random after stratifying by
number of inhabitants. In a third stage, participants from
each municipality were selected by simple random sam-
pling from the Catalan census register, after stratifying by
age and gender.
The two EQ-5D versions (3 L and 5 L) were included in
four waves (2nd to 5th) of the CHIS, conducted from Janu-
ary 2011 to December 2012 (N = 9658). Both versions of
EQ-5D were face-to-face, computer-assisted interviews, al-
ways administered in the same order: first the EQ-5D-3L
and next the EQ-5D-5L, followed by the visual analogue
scale. Furthermore, to assess the effect of administering the
two versions of EQ-5D together, we used data from the 6th
wave (the first one where EQ-5D-5L was administered
alone) to compare with the 5th wave (the last one where
the two EQ-5D versions were administered together).
To correct the effect of non-response, 49% of selected
sampling units needed to be replaced by others with the
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same characteristics in terms of age group, sex, and
neighborhood. Reasons for replacement were: refusal to
participate (25.9%), change of address (34.7%), prolonged
absence (17.8%), inaccessible dwelling (12.6%), wrong
address (4.0%), language skills (0.6%), death (1.4%), or
other reasons (3.0%).
Study variables
The EQ-5D is a generic, multi-attribute health status meas-
ure composed of a descriptive system, and a visual analogue
scale (VAS) asking individuals to rate their own health from
0 to 100 (the worst and best imaginable health, respect-
ively). The descriptive system covers five dimensions of
health, and response options include three or five levels of
severity according to the version. In general, the grading
terms for level 1 (no problems), and 5 (extreme problems/
unable to) on the EQ-5D-5L are consistent with the ex-
treme levels of the EQ-5D-3L, except for “confined to bed”
(EQ-5D-3L) vs. “unable to walk about” (EQ-5D-5L). Label
description on EQ-5D-5L is “slight” for level 2 and “severe”
for level 4 (except for anxiety/depression, with “slightly”
and “severely”). The Spanish value set of preferences elic-
ited with Time Trade Off (TTO) was applied to construct
the EQ-5D-3L index [33], while the EQ-5D-5L index was
calculated with the crosswalk 3 L–5 L value set [34], de-
rived from the original EQ-5D-3L preference weights [33].
This crosswalk 3 L–5 L value set was obtained using a
non-parametric indirect model [34] to generate values for
the 5 L by estimating the probabilities of being in each of
the 3 L levels. Thus, the theoretical ranges of the
EQ-5D-5L index calculated with the crosswalk value set
matched exactly with the 3 L index: from 1 (the best health
state) to − 0.65 (negative values in health states valued as
worse than death), where 0 is equal to death.
Sociodemographic variables recorded in the survey in-
cluded gender, age, level of education, and social class. So-
cial class was assigned according to the respondent’s most
recent occupation (or the head of the household’s occupa-
tion in the case of those who were looking after the
home), using an adapted version of the British Registrar
General Social Classes: classes I and II (managerial and
freelance professionals), class III (skilled non-manual oc-
cupations), class IV (skilled manual workers), and class V
(non-skilled manual workers) [35].
Health indicators collected in the CHIS included general
perceived health (rated as excellent, very good, good, fair
or poor), limitation of daily activities due to any health
problem during the previous 6 months, and a checklist of
28 common chronic conditions. Respondents were asked,
“Do you suffer from or have you suffered from any of the
following chronic conditions?” and had to answer “Yes” or
“No” for each condition. A summary indicator was derived
from the checklist, based on the number of reported
chronic conditions. This discrete variable was categorized
according to sample distribution into five groups: none, 1,
2, 3–4, and 5 or more chronic conditions.
Statistical analysis
The sample size of CHIS allows calculating the propor-
tion of individuals with the best health state among
those reporting stroke (the least prevalent condition
among the Catalan population) for an estimated percent-
age of 20% with a 95% confidence interval of +/− 5.
To restore the representativeness of the Catalan popula-
tion, taking into account the complex sampling process
followed (considering age, gender, and municipality), a
weighting factor was applied. In addition, design-based
standard errors and significance tests were estimated with
the Taylor series linearization method implemented in
SAS software, which account for the correlation structure
among individuals induced by the stratified and clustered
sampling design [36]. In order to determine the effect of
the sampling in the estimations, the design effects were
obtained as the ratio between two variances: the variance
of the estimator under the actual sample design to that
under simple random sampling of the same size.
Sample characteristics were described by calculating un-
weighted frequencies and weighted percentages. To evalu-
ate the response redistribution between the classical
EQ-5D and the new five level version, we first calculated
weighted percentages in each level of the EQ-5D-5L after
stratifying by responses to the EQ-5D-3L and, second, we
assessed the inconsistencies according to the method de-
scribed by Janssen et al. [37]. Briefly, from the 15 potential
3 L–5 L response pairs in each dimension, those skipping
the adjacent categories of the 5 L were defined as incon-
sistencies. To assess validity of the response redistribution
between three and five levels, we calculated the mean of
the perceived health VAS in each of these 15 subgroups of
potential pairs. Our hypothesis is that, except for incon-
sistencies, the perceived health (VAS) in subgroups of in-
dividuals selecting an EQ-5D-5L category with more
severe problems is worse than in subgroups remaining in
the same category of response to the EQ-5D-3L (or vice
versa, better perceived health in milder problems).
The discriminatory power was examined with Shan-
non Indices, which were calculated for each dimension
separately. The Shannon index is defined as:




where H′ represents the absolute amount of informativ-
ity captured, L is the number of levels, and pi = ni/N, the
proportion of observations in the ith level (i = 1,…, L), ni
being the observed number of responses in level i and N
the total sample size [38]. H′ reaches its maximum (H′
max) when distribution is uniform (rectangular) and it
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equals to log2 L. Shannon’s Evenness index (J’ =H′/H’max)
reflects the evenness (spread) of a distribution, regardless of
the number of levels. The 95% confidence intervals were
calculated according to the variance of the Shannon index:








As previously reported [37, 39, 40], we hypothesized
that the 5 L has more discriminatory power (larger H′
values) than the 3 L version, but lower Shannon Even-
ness index J’, reflecting that populations need a larger
spread to cover five levels than for three. Therefore, we
expected the H′ to increase (higher absolute levels of in-
formation) and J’ to stay equal or marginally decrease in
the 5 L version.
A plot between EQ-5D-3L index (y-axis) and EQ-5D-5L
index (x-axis) was constructed to graphically compare the
distribution of both indices. We also calculated the statistics
describing the distribution of EQ-5D indices: the theoretical
and observed ranges, the weighted proportion and 95%
confidence intervals (95% CI) of individuals with the best
and worst health state, and parameters of central tendency
and dispersion. Furthermore, a sensitivity analysis was per-
formed to examine the consistency of results when the
EQ-5D-5L index is estimated with 3 L–5 L crosswalk value
set or with the newly developed Spanish value set obtained
through a common composite method of TTO and
discrete choice experiments (DCE) [41]. We calculated the
statistics describing the distribution of the EQ-5D-5L index
constructed with this value set in the entire sample; as well
as after excluding participants with negative values in any
index, because the theoretical range of this new EQ-5D-5L
index (− 0.416 to 1) was not exactly coincident with the
EQ-5D-3L index (− 0.653 to 1) for values < 0.
To explore the distribution of EQ-5D indices in per-
sons with chronic conditions, the weighted proportion
(95% CI) of individuals reporting the best possible health
state (11111) in EQ-5D-3L and EQ-5D-5L within each
of the 28 specific chronic conditions’ groups was esti-
mated. Furthermore, the mean (95% CI) of the perceived
health VAS for this subgroup of individuals reporting the
best possible health state within each specific chronic
condition was calculated. Since we expected a lower pro-
portion of individuals reporting the best health state
(11111) with EQ-5D-5L than with EQ-5D-3L, we hy-
pothesized a better perceived health (VAS) when this
subgroup of individuals is defined by the EQ-5D-5L.
Finally, to assess the effect of administering the
EQ-5D-5L after the 3 L version, we compared the re-
sponses to the dimensions in the EQ-5D-5L between the
samples of the 5th (3 L and 5 L versions administered to-
gether) and 6th waves (EQ-5D-5L administered alone)
using a Chi-squared test.
Results
Of the 9658 participants in the CHIS between January
2011 and December 2012, 7554 individuals aged 18 to
102 years old were analyzed after excluding 2104 people
younger than 18. Mean age of participants was 47.1 (SD
= 18.9), and 50.9% were female (Table 1). More than half
had completed secondary studies, 40% belonged to social
class IV, and 48.5% suffered three or more chronic con-
ditions. Only 15% of the individuals reported some limi-
tation of activities in the previous 6 months, and 34.3%
claimed to have either excellent or very good perceived
health (Table 1).
Cross tabulations of responses to both EQ-5D versions
(Table 2) showed that most of the participants reporting no
problems in the 3L version remained at Level 1 in the 5L
version, and only 1–2% moved to slight problems. In con-
trast, a large proportion of individuals reporting extreme
problems in the 3L version had moved to severe problems
(Level 4) in the 5L version. This proportion was particularly
marked for pain/discomfort (75.5%) and anxiety/depression
(66.4%). Grey cells show the pairs previously defined as in-
consistencies. The number of inconsistencies was highest
in the pain/discomfort domain (n = 189; 2.4%) and lowest
in the self-care one (n = 54; 0.6%). The average proportion
of inconsistencies by dimension was 0.9%.
Regarding the validity of the redistribution between three
and five levels, the mean of the perceived health VAS was
over 75 in the subgroup of individuals reporting no prob-
lems in both versions for all dimensions (range 75.4–79.7).
Confirming the hypothesis established a priori, the per-
ceived health VAS mean in subgroups of individuals select-
ing an EQ-5D-5L category of more severe problems is
worse than in those remaining in the same category as in
the EQ-5D-3L. Similarly, those moving to milder problems
in the EQ-5D-5L presented better perceived health. For ex-
ample, in the last row of Table 2 (extremely anxious or de-
pressed in the EQ-5D-3L), the 66.4% who moved to a
milder level in the 5 L (severe problems) presented better
perceived health than those who remained at the extreme
level (11.5%): mean VAS of 41.7 vs. 29.5.
Figure 1 shows Shannon indices of EQ-5D-3L and
EQ-5D-5L. The maximum information captured by the
system (H’max in light bars), and also the absolute infor-
mativity (H′ in dark bars) is higher in 5 L than in 3 L
version. However, when H′ is compared with the H’max,
the relative information area captured (J’) is significantly
lower in EQ-5D-5L than in 3 L for all dimensions except
self-care. This difference is especially marked in pain/
discomfort (J’ = 0.59 vs. 0.68) and anxiety/depression (J’
= 0.42 vs. 0.50).
Figure 2 shows the plot between EQ-5D-3L and
EQ-5D-5L indices. The cloud of points and the biggest
clusters of individuals were concentrated around the
perfect agreement diagonal, indicating a high correlation
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between both indices. A slight deviation to higher values
with the EQ-5D-5L than the EQ-5D-3L is also
observable.
Table 3 shows the statistics describing distribution of
the EQ-5D indices. Ranges observed in our sample
matched exactly with the theoretical ranges (from −0.65
to 1). The proportion of individuals with the worst health
state was negligible (< 0.15%), while the proportion with
the best health state was 61.8% with EQ-5D-3L and 60.8%
with EQ-5D-5L. Means (SD) were 0.87 (0.25) and 0.89
(0.22) for EQ-5D-3L and EQ-5D-5L. Sensitivity analysis
performed with the EQ-5D-5L index constructed with the
newly developed Spanish value set [41] (see Add-
itional file 1) showed consistent results: mean 0.90 (SD =
0.19) in the entire sample, and mean 0.92 (SD = 0.14) after
excluding the 249 subjects with negative values. Differ-
ences between EQ-5D-3L and EQ-5D-5L indices
remained quite stable regardless the value set used.
Figure 3 shows results by each specific chronic
condition: the proportion of individuals with the best
Table 1 Sample characteristics of the Catalan Health Interview Survey (2011–2012)
n (%) Unweighted n (%) Weighted SEa Design effect
Gender
Male 3791 (50.2%) 3877 (49.1%) 0.20 0.19
Female 3763 (49.8%) 4014 (50.9%) 0.20 0.19
Age group
18–44 years 3527 (46.7%) 3801 (48.2%) 0.45 0.62
45–64 years 2259 (29.9%) 2436 (30.9%) 0.76 2.08
65–74 years 753 (10.0%) 784 (9.9%) 0.33 0.92
75 years and over 1015 (13.4%) 870 (11.0%) 0.29 0.53
Studies level
Primary or less 2015 (26.7%) 1993 (25.3%) 2.19 18.52
Secondary 4179 (55.4%) 4345 (55.1%) 1.65 8.31
University or more 1356 (18.0%) 1548 (19.6%) 3.44 60.70
Social class
I-II (managerial and free-lance professionals) 1312 (18.0%) 1485 (19.5%) 2.83 40.90
III (skilled non-manual occupations) 2226 (30.6%) 2390 (31.3%) 2.36 19.84
IV (skilled manual workers) 3067 (42.2%) 3052 (40.0%) 4.71 68.95
V (non-skilled manual workers) 671 (9.2%) 701 (9.2%) 0.59 3.18
Perceived health
Excellent 564 (7.5%) 636 (8.1%) 0.82 7.41
Very good 1895 (25.1%) 2067 (26.2%) 1.64 10.84
Good 3388 (44.9%) 3452 (43.7%) 2.08 13.25
Fair 1356 (18.0%) 1374 (17.4%) 0.48 1.20
Poor 351 (4.7%) 362 (4.6%) 0.41 2.82
Activity limitation
Yes, seriously affected 398 (5.3%) 397 (5.0%) 0.33 1.60
Yes, limited but not seriously 762 (10.1%) 786 (10.0%) 0.63 3.33
No 6394 (84.6%) 6708 (85.0%) 0.85 4.19
Number of chronic physical conditions
None 1690 (22.4%) 1783 (22.6%) 1.60 11.21
1 condition 1183 (15.7%) 1256 (15.9%) 0.55 1.75
2 conditions 981 (13.0%) 1017 (12.9%) 0.50 1.66
3 or 4 conditions 1432 (19.0%) 1526 (19.3%) 0.47 1.07
5 or more conditions 2268 (30.0%) 2308 (29.2%) 1.36 6.68
VAS (mean, SD) 7554 73.19 (19.21) 0.42 5.21
aStandard error was estimated by the Taylor series method
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health state (11111) in the EQ-5D-3L (blue bars)
and EQ-5D-5L (green bars), and also the mean (95%
CI) of perceived health VAS in subgroups with and
without the best health state. In both indices,
chronic allergies presented the highest proportion of
subjects with the best health state (50.6 and 50.1%),
and urinary incontinence the lowest (13.1 and
12.0%). Regardless of the index used, the proportion
of individuals with the best health state was ≤ 30%
in half of the chronic conditions from the checklist
(cervical pain, tumors, arthrosis, arthritis or rheuma-
tism, peptic ulcer, poor circulation, other health ill-
nesses, cataracts, myocardial infarction, chronic
constipation, anxiety or depression, other mental dis-
orders, stroke, osteoporosis, and urinary incontin-
ence). The mean of the VAS for the subgroup with
the best possible health state defined by EQ-5D-3L
and EQ-5D-5L (in dark blue and green lines, re-
spectively) was over 70 within all specific chronic
condition groups, ranging 71.3–79.8 and 72.6–81.3,
respectively. Perceived health VAS means in the sub-
groups defined by the EQ-5D-3L were very similar
to those obtained in the subgroups defined by
EQ-5D-5L. For the subgroup with some health prob-
lem (not 11111), mean of VAS was always lower
than 60 (light blue and green lines).








































































































Some problems with performing

































































































N unweighted, (weighted % by response to EQ-5D-3L) and [mean VAS]. Inconsistencies are marked in bold
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Discussion
This head-to-head comparison of EQ-5D-5L with
EQ-5D-3L in the general population of Catalonia shows
that redistribution of levels is mostly in individuals
reporting extreme problems on the EQ-5D-3L, which
moved to level 4 on the EQ-5D-5L, but not for those
reporting no problem, who remained at the top. This ex-
plains the very small reduction in the percentage of indi-
viduals with the best health state, from 61.8% with
EQ-5D-3L to 60.8% with EQ-5D-5L, and the increment
of the index mean (from 0.87 to 0.89) in our sample.
One of the original contributions of this study is
that, as far as we are aware, this is the first time
that distribution and validity of the EQ-5D-5L have
been compared head-to-head to those of the
EQ-5D-3L in a health survey on general population.
In the Lombardy study both versions were also ad-
ministered, but they were not compared since the
publication was focused on reference norms [31].
Our study has some limitations. Firstly, the two versions
of the EQ-5D were always administered in the same order:
first the 3 L and then the 5 L. This proximity might have
affected the EQ-5D-5L, which was always administered
second. However, the comparison with the 6th wave (see
Additional file 2), where only the EQ-5D-5L was adminis-
tered, showed no differences in EQ-5D-5L dimensions,
except for pain/discomfort (72.4% versus 67.6% of individ-
uals reporting no problem, p = 0.003). This finding indi-
cates that the fact of administering the two versions
together did not modify the response to the EQ-5D-5L
when administered alone (as in the 6th wave). Further-
more, results from the 2011 National Health Survey of
Fig. 1 Discriminatory power measured by Shannon Indices for 3 L and 5 L version. Footnote: Absolute Informativity (H′) represented by dark bars
and Maximum Absolute Informativity (H’max) represented by light bars. The Relative Informativity (J’) is the proportion of H′/H’max
Fig. 2 Plot between EQ-5D-3L and EQ-5D-5L indices. Footnote: The EQ-5D-3L index was calculated with the conventional Time Trade Off
preference values from the Spanish general population [33]; and the EQ-5D-5L index was calculated with the 3 L–5 L crosswalk from Spain [34]
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Spain (62.4% of individuals with the best health state)
where only the 5 L version was administered [42] also sup-
port our EQ-5D-5 L findings in Catalonia. Secondly, an
interviewer bias may have played a role, and this could be
differential for those dimensions where the wording of the
response option had been modified in the EQ-5D-5L. For
example, in the extreme of mobility (“confined to bed” for
the EQ-5D-3L versus “unable to walk about” for the
EQ-5D-5L), interviewers might have attenuated the sever-
ity. Finally, our sample is only representative of Catalonia.
However, given the similarities in national indicators such
as life expectancy or healthy life years in the general popu-
lation of Catalonia, Spain, and other European regions
[43], it is likely that our results will be generalizable to
similar developed countries.
The small reduction observed in the percentage of in-
dividuals with the best health state, from 61.8% with
EQ-5D-3L to 60.8% with EQ-5D-5L, is due to the negli-
gible movement from level 1 out of 3 (“no problem”) to
level 2 out of 5 (“slight problems”) in all dimensions.
This absolute reduction of 1% (relative reduction of
1.6%) in the proportion of individuals with the best
health state was lower than that reported in the popula-
tion of South Korea and Lombardy (absolute reductions
of 4.5, and 5.9%, respectively) [28, 31]. The Canadian
and English studies [29, 30] reported greater differences
of 9.8 and 8.6%; but as previously remarked, they were
not head-to-head comparisons, so this could be ex-
plained by other reasons related to the study design, ra-
ther than to differences between EQ-5D versions.
This is the first time that redistribution of a large pro-
portion of individuals from extreme to severe problems
has been reported in a general population. Depending on
the dimension, between 18.3 and 75.7% of individuals
reporting extreme problems in the 3 L version moved to
level 4 (severe problems) in the 5 L one. The better per-
ceived health in this latter subgroup (VAS mean over 40
in most domains), compared with the subgroup remaining
in extreme problems (VAS mean ranging from 29.5 in
anxiety/depression to 36.5 in self-care), supports the valid-
ity of the redistribution phenomenon observed in the side
of the EQ-5D descriptive system indicating poor health.
This may indicate that the EQ-5D-5L can measure the
health state of individuals with severe (but not extreme)
health problems in the Catalan general population better
than the EQ-5D-3L. This partly explains why the index
mean of the new version was higher (0.89) than that ob-
tained with the traditional version with three levels (0.87).
Table 3 Distribution of the EQ-5D-3L and EQ-5D-5L indices
(total sample and positive values subsamplea)
EQ-5D-3L EQ-5D-5L
Total sample N = 7554 N = 7554
Theoretical range −0.653, 1 − 0.654, 1
Observed range − 0.653, 1 −0.654, 1














0.87, SD = 0.25
(0.86, 0.88)






aAfter excluding participants with negative values in any index
The EQ-5D-3L index was calculated with the conventional Time Trade Off
preference values from the Spanish general population [33]; and the EQ-5D-5L
index was calculated with the 3 L–5 L crosswalk from Spain [34]
Fig. 3 EQ-5D-3L (blue) and EQ-5D-5 L (green): Individuals with best health state within each chronic condition. Footnote: Bars show weighted
proportions and 95% CI of individuals with best health (11111). Lines show mean of VAS and 95% CI: best possible health, 11111 (dark); some
health problem (light)
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Due to its small sample size (N = 600), the South Korean
study could not observe this redistribution because there
were too few participants on level 3 of EQ-5D-3L (0–6 in-
dividuals) [28], while the Italian study did not assess the
redistribution [31]. It is important to highlight the low
average proportion of inconsistencies between both
EQ-5D versions in our study (0.9%), which was compar-
able to the South Korean general population (1.1%) [28],
and lower than that reported among patients with cancer
(3.5%) [25] or with chronic conditions (2.9%) [39].
As expected, extending the EQ–5D descriptive system
from three to five levels resulted in significantly higher
absolute, but slightly lower relative (evenness) discrimin-
atory power. J’ values have also been found slightly lower
in some dimensions of EQ-5D-5L in previous compara-
tive studies [37, 39, 40]. The absolute and relative infor-
mativity of both EQ-5D versions in our study (0.36–1.37
and 0.21–0.68, respectively) were similar to those re-
ported by Pattanaphesaj et al. [40] (0.12–1.40 and 0.08–
0.63), but lower than those observed in others [37, 39].
The relatively good health of people from the Catalan
general population could partly explain the lower abso-
lute informativity observed in our study.
The difference observed between EQ-5D-3L and
EQ-5D-5L indices for medians and means (SD) merits a
comment. The EQ-5D-5L index presented a slightly
higher median and mean, but a reduced SD compared
with the EQ-5D-3L index. Since the crosswalk 3 L–5 L
value set applied to calculate the EQ-5D-5L index had
been derived from that originally developed for the 3 L
version, these differences may be mainly explained by the
increment in the number of levels. For this reason, it is
recommendable that national health surveys using the
EQ-5D-3L that decide to replace it with the EQ-5D-5L
maintain both versions, at least in a random subsample,
for a temporary period. Results in these subsamples will
allow anchoring results of the two versions, in order to
take into account the version effect and correctly monitor
the evolution of health along time. Otherwise, changes ob-
served when monitoring populations could be mistakenly
attributed to health worsening/improvement instead of
measurement differences between versions.
The most prevalent chronic conditions in this sample
were low back pain (30%), arthrosis, arthritis or rheuma-
tism (27.8%), and high blood pressure (25.6%), while
stroke was the least prevalent with a rate of 2.4% (data
not shown). Contrarily to the a priori hypothesis, both
EQ-5D versions had an almost identical validity measur-
ing health in individuals who self-reported chronic con-
ditions and with the best health state. This unexpected
result is probably explained by the very similar percent-
age of individuals with the best health state within each
specific chronic condition, regardless of the EQ-5D ver-
sion. Although larger reductions in this percentage were
reported in studies of specific conditions such as hepa-
titis B (21.6 to 16.7%) [26] and surgery patients (30 to
18%) [27], the decline observed in the groups with spe-
cific chronic conditions within our sample was ≤3% in
all cases. This difference could be due to self-reporting
instead of clinical diagnoses.
Conclusions
The increase of levels provided by the EQ-5D-5L con-
tributed to the validity and discriminatory power of this
new version. The group of individuals with poor health
was redistributed into different severity levels, while in
the EQ-5D-3L they were stuck in the category of ex-
treme problems. The proportion of individuals with the
best health state is still very high in the EQ-5D-5L.
Nonetheless, results of perceived health VAS support
validity of the observed redistribution. Furthermore,
consistency between both EQ-5D versions and with re-
sults from the 2011 Spanish National Health Survey en-
hance the reliability of responses from this subset of
general population in good health.
Our findings support the validity and discriminatory
power of the new EQ-5D-5L for health measurement of
the general population. However, it would be advisable
to maintain both versions in parallel for a temporary
period when introducing the new EQ-5D-5L to a na-
tional health survey currently using the EQ-5D-3L ver-
sion in order to establish an anchor.
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